Navigation Links
Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair'

- Event to be Held January 27th at 7:00 p.m. Eastern Time in Conjunction with

Leading Cardiothoracic Surgeons Conference - REDWOOD CITY, Calif. and SUNNYVALE, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) and Intuitive Surgical, Inc. (Nasdaq: ISRG) today announced they will host an evening symposium on the topic of "Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair." The symposium will feature Intuitive's da Vinci(R) Surgical System and Cardica's innovative C-Port (R) Distal Anastomosis Systems, which are designed to allow surgeons to automate the attachment of blood vessel grafts during coronary artery bypass graft (CABG) procedures, replacing traditional hand-sewn sutures.

The educational event will take place on Sunday, January 27, from 7 to 9 p.m. Eastern Time at the Renaissance Hotel Grand Ballroom in Fort Lauderdale, Fla. during the 44th Annual Meeting of The Society of Thoracic Surgeons (STS), the largest meeting of cardiothoracic surgeons in North America. This activity is not part of the official scientific program of STS.

"This symposium offers cardiothoracic surgeons an opportunity to learn from their peers who are leading the adoption of beating heart robotic CABG surgery and the establishment of robotic mitral valve surgery as standard of care," said Louis A. Brunsting, III, M.D., cardiothoracic surgeon for Centennial Medical Center in Nashville, Tennessee. "The Cardica C-Port systems and da Vinci Surgical System featured during this symposium have the potential to revolutionize the field of cardiothoracic surgery, as they may facilitate a more widespread adoption of completely closed-chest, robotic-assisted coronary artery bypass grafting."

During the symposium, five leading cardiac surgeons will present on the following topics:

-- Husam Balkhy, M.D., of The Wisconsin Heart Hospital -- "Clinical

Outcomes in Revascularization of the LIMA to LAD with an Automated

Anastomotic Device"

-- Daniel Bethencourt, M.D., of Long Beach Memorial Medical Center -- "A

Stepwise Approach to Building a Robotic Cardiac Surgery Program"

-- Louis A. Brunsting, III, M.D., of Centennial Medical Center -- "An

Evolution in Robotic Revascularization"

-- Douglas A. Murphy, M.D., of Saint Joseph's Hospital -- "Endoscopic

Mitral Valve Surgery -- Toward Complete Repairability"

-- J. Michael Smith, M.D., of Good Samaritan Hospital -- "The Convergence

of Technology in Robotic Mitral Valve and Coronary Artery Bypass


To register for the symposium, please contact Angie Lupkes at 608-215-4520 or or visit Cardica's booth (#625) at the STS conference.

About the C-Port xA and Flex A Anastomosis Systems

Cardica's C-Port systems are designed to enable automated, reliable and reproducible connections of blood vessels during CABG surgery. Unlike most hand-sewn anastomoses, Cardica's C-Port systems create compliant anastomoses that can expand and contract with blood flow. In addition, the C-Port anastomosis systems, whether used during on- or off-pump surgery, offer surgeons unique access to a wide range of coronary arteries, particularly small coronary arteries on which, in the past, CABG procedures have been very difficult or impossible to perform. The C-Port Flex A system features several innovative modifications to Cardica's C-Port xA system. The C-Port Flex A system has a flexible, rather than rigid, shaft and is designed to create compliant anastomoses in vessels as small as one millimeter in internal diameter. Importantly, the flexible shaft is designed to allow surgeons to position the device to create a secure connection even in difficult to reach areas of the heart.

About the da Vinci(R) Surgical System

The da Vinci Surgical System is a sophisticated robotic platform designed to enable complex surgery using a minimally invasive approach. The da Vinci System consists of an ergonomic surgeon's console, a patient-side cart with four interactive robotic arms, a high-performance vision system and proprietary EndoWrist(R) instruments. Powered by state-of-the-art robotic technology, the da Vinci System is designed to scale, filter and seamlessly translate the surgeon's hand movements into more precise movements of the EndoWrist instruments. The net result is an intuitive interface with breakthrough surgical capabilities. By providing surgeons with superior visualization, enhanced dexterity, greater precision and ergonomic comfort, the da Vinci Surgical System makes it possible for more surgeons to perform minimally invasive procedures involving complex dissection or reconstruction. This ultimately raises the standard of care for complex surgeries, translating into numerous potential patient benefits, including less pain, a shorter recovery and quicker return to normal daily activities.

About Cardica

Cardica is a leading provider of automated anastomosis systems for coronary artery bypass graft (CABG) surgery. By replacing hand-sewn sutures with easy-to-use automated systems, Cardica's products provide cardiovascular surgeons with rapid, reliable and consistently reproducible anastomoses, or connections of blood vessels, often considered the most critical aspect of the CABG procedure. Cardica's C-Port(R) Distal Anastomosis Systems are marketed in Europe and the United States. The PAS-Port(R) Proximal Anastomosis System is marketed in Europe and Japan and is being evaluated in a pivotal trial in the United States and Europe. Cardica also is developing additional devices with Cook Incorporated to facilitate vascular closure and other surgical procedures.

Forward-Looking Statements

This press release contains "forward-looking" statements, including statements relating to the potential impact the adoption of Cardica's C-Port systems may have on the future success of closed-chest CABG procedures. Any statements contained in this press release that are not historical facts may be deemed to be forward-looking statements. The word "may" and similar expressions are intended to identify forward-looking statements. There are a number of important factors that could cause Cardica's results to differ materially from those indicated by these forward-looking statements, including risks associated with market acceptance of Cardica's C-Port systems and long-term patency of CABG grafts completed with Cardica's C-Port systems, as well as other risks detailed from time to time in Cardica's SEC reports, including its Quarterly Report on Form 10-Q for the fiscal quarter ended September 30, 2007. Cardica does not undertake any obligation to update forward-looking statements. You are encouraged to read Cardica's reports filed with the U.S. Securities and Exchange Commission, available at

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are necessarily estimates reflecting the best judgment of our management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be considered in light of various important factors, including the following: timing and success of product development and market acceptance of developed products; regulatory approvals, clearances and restrictions; guidelines and recommendations in the health care and patient communities; intellectual property positions and litigation; competition in the medical device industry and in the specific markets of surgery in which Intuitive Surgical operates; and unanticipated manufacturing disruptions; delays in regulatory approvals of new manufacturing facilities or the inability to meet demand for products. Words such as "estimate", "project", "plan", "intend", "expect", "anticipate", "believe" and similar expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. We undertake no obligation to publicly update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
2. Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
3. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
4. Surgical and Trauma Wound Care Market to Tie Up $7 Billion in Sales by 2011
5. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
6. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
7. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
8. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
9. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
10. Magnifi Group Demonstrates Industrys First Interactive Educational Program (IEP) for Spine Fellows
11. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
Post Your Comments:
(Date:11/25/2015)... 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: ... prospects remain fundamentally strong and highlights the following ... received DSMB recommendation to continue the ZoptEC Phase ... the final interim efficacy and safety data ... men with heavily pretreated castration- and Taxane-resistant prostate ...
(Date:11/25/2015)... SAN DIEGO , Nov. 25, 2015 ... that management will participate in a fireside chat discussion ... New York . The discussion is ... Time. .  A replay will ... Contact:  Media Contact:McDavid Stilwell  , Julie NormartVP, Corporate ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... company uBiome, were featured on AngelList early in their initial angel funding process. ... AngelList syndicate for individuals looking to make early stage investments in the microbiome ...
(Date:11/24/2015)... , ... November 24, 2015 , ... The United States ... of the 2016 USGA Green Section Award. Presented annually since 1961, the USGA Green ... or her work with turfgrass. , Clarke, of Iselin, N.J., is an ...
Breaking Biology Technology:
(Date:11/12/2015)...  Arxspan has entered into an agreement with ... use of its ArxLab cloud-based suite of biological ... will support the institute,s efforts to electronically manage ... internally and with external collaborators. The ArxLab suite ... Institute,s electronic laboratory notebook, compound and assay registration, ...
(Date:11/10/2015)... About signature verification Signature ... identify and verify the identity of an individual ... secure and accurate method of authentication and is ... because each individual,s signature is highly unique. Signature ... signature of an individual is compared and matched ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
Breaking Biology News(10 mins):